• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareHealthcare Equipment & SuppliesInspireMD
    Picture of InspireMD logo

    NSPR — InspireMD Share News

    $0.720.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapNeutral
    • Market Cap
      $33.72m
    • Enterprise Value
      -$7.85m
    • Revenue
      $8.98m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • NSPR Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    NSPR Dividends
    • Brief: InspireMD Reports Third Quarter 2021 Financial Results

      09/11/2021 12:38
    • Brief: InspireMD Reports Publication of 12-Month Results of CGuard EPS SIBERIA Trial

      03/11/2021 22:05
    • Brief: InspireMD Inc Receives Reimbursement Approval For CGUARD Embolic Prevention System From The French National Authority For Health

      13/10/2021 14:43
    • Brief: InspireMD Announces Strong Second Quarter 2021 Financial Results

      10/08/2021 12:08
    • InspireMD Inc reports results for the quarter ended in June - Earnings Summary

      09/08/2021 23:35
    • InspireMD Inc expected to post a loss of 63 cents a share - Earnings Preview

      06/08/2021 13:18
    • InspireMD Inc expected to post a loss of 63 cents a share - Earnings Preview

      30/07/2021 17:33
    • InspireMD: Rises on positive data from carotid artery disease study

      10/06/2020 15:40
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.